Luo Xin Fu

Luo Xin Fu is the dried root and rhizome of Astilbe chinensis (Maxim.) Franch. & Sav., a perennial herbaceous plant in the family Saxifragaceae. In the traditional TCM classification system, Luo Xin Fu is considered bitter in flavor and slightly warm in nature. It enters the Liver, Spleen, and Kidney meridians, giving it a traditional role in addressing Heat, toxicity, bleeding, and swelling patterns.

Botanical description: Astilbe chinensis is a herbaceous perennial growing 50–100 cm tall from a thick, woody rhizome. The leaves are compound with serrated leaflets, giving them a somewhat fern-like appearance. In summer, the plant produces feathery plumes of small pink to reddish flowers in dense, pyramidal panicles. It is native to East Asia, including China, Japan, Korea, and eastern Russia. Below ground, the plant develops a stout rhizome with fibrous roots. The dried rhizome and roots are reddish-brown to dark brown in color, irregular in shape, and have a characteristic bitter taste.

Habitat and distribution: A. chinensis grows in moist, shaded environments including forest margins, stream banks, and mountain valleys. In China, it is found in northern, northeastern, and central provinces. It is also widely cultivated as an ornamental garden plant for its attractive flower plumes and tolerance of shade. The medicinal material is typically collected from wild populations in autumn after the aerial parts have withered. The rhizome and roots are cleaned, sliced, and dried for medicinal use.

Quality markers: Unlike major pharmacopoeial herbs, Luo Xin Fu does not have extensive standardized quality specifications in national pharmacopoeias. In folk practice, high-quality material is described as having a firm, solid rhizome, a dark brown to reddish-brown exterior, and a distinctly bitter taste. The material should be free from mold, insect damage, and excessive foreign matter. Modern phytochemical studies have identified bergenin, triterpenes, and phenolic compounds as characteristic chemical markers of the species.

In the traditional Chinese medicine theoretical framework, Luo Xin Fu is understood as a folk herb for clearing Heat, resolving toxicity, stopping bleeding, and reducing swelling. Because it enters the Liver, Spleen, and Kidney meridians and has a bitter, slightly warm quality, it is traditionally indicated for patterns involving Heat, toxicity, and bleeding.

Clearing Heat and resolving toxicity: Luo Xin Fu is traditionally used to clear Heat and resolve toxicity, particularly for sore throat, swollen gums, and skin conditions attributed to Heat-toxin patterns. In folk practice, it may be used alone or in simple combinations with other heat-clearing herbs for these purposes. Its bitter nature is traditionally associated with the ability to drain Heat and dry Dampness.

Stopping bleeding: Luo Xin Fu has a traditional use for stopping bleeding, both internally and externally. For traumatic bleeding, the fresh or dried herb may be crushed and applied topically. For internal bleeding patterns associated with Heat forcing Blood out of the vessels, it may be used in decoction. This traditional use is thought to be related to its tannin content, which has astringent properties.

Reducing swelling and relieving pain: In folk medicine, Luo Xin Fu is used to reduce swelling and relieve pain from traumatic injury, sprains, and bruises. It may be applied externally as a poultice or wash for these purposes. The traditional understanding is that by invigorating Blood circulation and clearing localized Heat and stagnation, the herb helps to resolve swelling and promote healing of injured tissues.

Abdominal pain and bloating: In some regional folk traditions, Luo Xin Fu is used for abdominal pain and bloating, particularly when these symptoms are attributed to stagnation or minor digestive disturbance. Its traditional association with the Spleen and Liver meridians underlies this application. However, it is not a primary herb for digestive disorders in mainstream TCM practice.

Regional folk usage: Luo Xin Fu is primarily a folk herb rather than a core ingredient in classical TCM formulas. Its use is documented in regional materia medica and folk medicine records from northern and central China. It does not appear in the earliest classical texts such as the Shen Nong Ben Cao Jing, but is recorded in later regional and folk collections of medicinal plants. Its dual value as both a medicinal plant and an ornamental has contributed to its continued cultivation and use.

Luo Xin Fu contains a range of bioactive compounds that have been the subject of phytochemical investigation. The following overview summarizes the major chemical constituents identified in the root and rhizome of Astilbe chinensis and what is currently known about them from published research.

Tannins and phenolic acids: Luo Xin Fu is rich in tannins, which are polyphenolic compounds with astringent properties. Bergenin, a C-glycoside of 4-O-methylgallic acid, is one of the most characteristic phenolic constituents identified in the rhizome. A bergenin derivative, 11-O-(3'-O-methylgalloyl)-bergenin, has also been isolated. These phenolic compounds have been investigated for potential anti-inflammatory, antioxidant, and anti-diabetic activities in pre-clinical models. Their astringent properties are traditionally associated with the herb's use in stopping bleeding.

Triterpenoid saponins and triterpenes: The rhizome of A. chinensis contains various triterpenoid compounds. Research has identified several novel triterpenes including astilbotriterpenic acid, an ursane-type triterpenoid, as well as oleanane-type triterpenes such as 3beta,6beta-dihydroxyolean-12-en-27-oic acid. Some of these compounds have been studied for cytotoxic and apoptosis-inducing effects in cell line experiments. Triterpenoid saponins have also been reported from the genusAstilbe, though their pharmacological profiles in the context of whole-herb preparations are not well established.

Flavonoids: Flavonoids have been identified as part of the phenolic fraction of A. chinensis. These compounds are widely distributed in the plant kingdom and are known for their antioxidant and anti-inflammatory properties. In Astilbe species, flavonoids may contribute to the overall pharmacological profile alongside tannins and triterpenes, though specific flavonoid constituents of A. chinensis have not been as extensively characterized as those of some other medicinal plants.

Other constituents: The rhizome also contains various other secondary metabolites including sterols and carbohydrates. Recent genomic studies have revealed the presence of terpene biosynthetic gene clusters in A. chinensis, suggesting a complex secondary metabolism that may yield additional bioactive compounds upon further investigation.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Luo Xin Fu is not a core ingredient in major classical TCM formulas. Instead, its use is primarily documented in regional folk medicine traditions. Below is an overview of its traditional folk applications rather than formal classical formula compositions.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-inflammatory effects: Several pre-clinical studies have investigated the anti-inflammatory potential ofAstilbe chinensis extracts. A study by Gil et al. (2020) reported that an ethanol extract of A. chinensis suppressed inflammation in lipopolysaccharide-stimulated macrophages via inhibition of the NF-kappaB signaling pathway. Another study by Han et al. (2024) found that an ethanol extract from A. chinensis inflorescence suppressed inflammatory responses in macrophages and inhibited the growth of oral pathogenic bacteria. These findings suggest potential anti-inflammatory mechanisms, but their clinical relevance in humans has not been established.

Platelet function modulation: Jeon et al. (2018) investigated the effects of A. chinensis on platelet function and reported that it modulated platelet aggregation via effects on MAPK and PLCgamma2 expression pathways. This pre-clinical finding raises theoretical considerations for individuals taking antiplatelet or anticoagulant medications, though clinical interaction data in humans are lacking.

Cytotoxic and apoptosis-inducing triterpenoids: Pre-clinical research has identified cytotoxic triterpenoids from the rhizome ofA. chinensis. Zhang et al. (2008) reported that astilbotriterpenic acid, a novel ursane-type triterpenoid, induced apoptosis in tested cell lines. Sun and Pan (2004) described the cytotoxic activity of 3beta,6beta-dihydroxyolean-12-en-27-oic acid. These findings are derived from in-vitro experiments and do not establish clinical anti-cancer efficacy in humans.

Acute lung injury research: A recent network pharmacology and experimental validation study by Liu et al. (2025) explored the potential mechanisms of A. chinensis for acute lung injury. The study identified multiple targets and pathways, and in-vivo experiments demonstrated effects on macrophage polarization and pulmonary function parameters in animal models. While scientifically interesting, these results cannot be extrapolated to human clinical efficacy without robust clinical trials.

Genomic and biosynthetic research: Chen et al. (2025) published a chromosome-level genome assembly of A. chinensis, revealing the evolution of a terpene biosynthetic gene cluster. This fundamental research provides insights into the plant's capacity to produce diverse secondary metabolites and may guide future phytochemical discovery. It does not, however, establish clinical applications for the herb.

What the research does NOT show: Despite promising pre-clinical signals, the research on Luo Xin Fu and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Luo Xin Fu can treat, cure, or prevent inflammatory disorders, cardiovascular disease, cancer, lung injury, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Luo Xin Fu as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Luo Xin Fu is a folk herb with very limited modern safety data. Unlike major pharmacopoeial herbs, it has not been subject to extensive toxicological evaluation or clinical safety monitoring. The information below reflects what is currently known from published literature and traditional experience, but significant uncertainties remain.

Limited safety data: Robust toxicological studies on Luo Xin Fu are lacking. There are no well-designed human clinical trials establishing its safety profile, optimal dosage range, or potential adverse effects. Pre-clinical studies in cell lines and animal models have reported cytotoxic effects of isolated triterpenoids at certain concentrations, but the relevance of these findings to whole-herb consumption in humans is unknown. Due to these data limitations, caution is warranted.

Deficiency-cold patterns: In traditional TCM theory, Luo Xin Fu is bitter and slightly warm. Individuals with deficiency-cold constitutions — characterized by cold limbs, loose stools, aversion to cold, and a pale tongue — should use it with caution. Its bitter, drying nature may theoretically aggravate cold patterns. As with all herbs, use should be guided by TCM pattern differentiation.

Pregnancy and lactation: Due to the lack of safety data, Luo Xin Fu should be avoided during pregnancy and lactation. The cytotoxic and apoptosis-inducing effects reported for some isolated constituents in pre-clinical studies raise theoretical concerns, though the relevance to whole-herb use is uncertain. Do not use Luo Xin Fu during pregnancy or while breastfeeding without direct supervision from a qualified healthcare professional.

Drug interactions: Pre-clinical data suggest that A. chinensis may modulate platelet function, raising theoretical concerns about interactions with anticoagulant and antiplatelet medications such as warfarin, aspirin, and clopidogrel. Additionally, compounds in the herb may affect inflammatory signaling pathways and could theoretically interact with immunosuppressive or anti-inflammatory drugs. Clinical interaction data are completely lacking. Consult a qualified healthcare professional before combining Luo Xin Fu with any prescription medications.

Allergies: Individuals with known allergies to plants in the Saxifragaceae family should avoid Luo Xin Fu. As with any herbal product, allergic reactions including skin rash, itching, or respiratory symptoms are possible, though specific reports for this herb are limited in the published literature.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Luo Xin Fu or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.